scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Talbot F | |
Nouwen A | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1556-1562 | |
P577 | publication date | 2000-10-01 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | A review of the relationship between depression and diabetes in adults: is there a link? | |
P478 | volume | 23 |
Q36344452 | A test for common genetic and environmental vulnerability to depression and diabetes |
Q35646143 | Alternative therapies useful in the management of diabetes: A systematic review. |
Q43788541 | Antidepressant use before and after initiation of diabetes mellitus treatment. |
Q37260751 | Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005-6. |
Q42229142 | Applying syndemics and chronicity: interpretations from studies of poverty, depression, and diabetes. |
Q33848986 | Assessing rumination in response to illness: the development and validation of the Multidimensional Rumination in Illness Scale (MRIS). |
Q35173316 | Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol. |
Q28546295 | Association between poor glycemic control, impaired sleep quality, and increased arterial thickening in type 2 diabetic patients |
Q43734829 | Association between symptoms of depression and glycaemic control may be unstable across gender. |
Q34659623 | Association of depression with type 2 diabetes and relevant factors |
Q47576285 | Beliefs and attitudes of African Americans with type 2 diabetes toward depression |
Q40271656 | Beyond Comorbidity: A Critical Perspective of Syndemic Depression and Diabetes in Cross-cultural Contexts. |
Q34729968 | Bidirectional association between depression and type 2 diabetes mellitus in women |
Q34345094 | Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes |
Q35063933 | Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase II |
Q35613977 | Comparison of health-related quality-of-life measurement instruments in diabetic patients |
Q37590757 | Cross-country differences in the association between diabetes and disability |
Q92897501 | Deconstructing Diabetes and Depression: Clinical Context, Treatment Strategies, and New Directions |
Q56875848 | Depression and Anxiety in Older and Middle-aged Adults With Diabetes |
Q34723038 | Depression and glycemic control in Hispanic primary care patients with diabetes |
Q38166326 | Depression and quality of life in youth-onset type 2 diabetes mellitus |
Q35820982 | Depression and recovery of daily life autonomy in patients with stroke receiving home rehabilitative treatment |
Q37599875 | Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications |
Q37695712 | Depression and type 2 diabetes in low- and middle-income countries: a systematic review |
Q38195477 | Depression and type 2 diabetes: a causal association? |
Q82747467 | Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis |
Q40381959 | Depression in Mexican Americans with diagnosed and undiagnosed diabetes |
Q37187830 | Depression in romanian patients with type 2 diabetes: prevalence and risk factors |
Q50446545 | Depression status as a reliable predictor of functional decline among Japanese community-dwelling older adults: a 12-year population-based prospective cohort study |
Q33550761 | Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study |
Q44877055 | Depression. An underestimated risk for the development and progression of coronary heart disease |
Q30824944 | Depressive symptom clusters as predictors of 6-year increases in insulin resistance: data from the Pittsburgh Healthy Heart Project |
Q40375915 | Depressive symptoms and life satisfaction in elderly women are associated with natural killer cell number and cytotoxicity. |
Q33751510 | Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of aging |
Q47857456 | Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample |
Q50490771 | Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. |
Q37639318 | Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes |
Q36453540 | Diabetes and depression comorbidity and socio-economic status in low and middle income countries (LMICs): a mapping of the evidence |
Q79327261 | Diabetes and depression: the role of social support and medical symptoms |
Q38492964 | Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007. |
Q36113565 | Diabetes and depressive symptoms among Korean American older adults: the mediating role of subjective health perceptions |
Q35352490 | Diabetes and psychiatric disorders |
Q37224588 | Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group) |
Q36468075 | Diabetes mellitus as a model of psychosomatic and somatopsychic interrelationships |
Q46752823 | Diabetes, depression, and healthcare utilization among African Americans in primary care |
Q34991066 | Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? |
Q37250144 | Dietary treatment options for depression among diabetic patient, focusing on macronutrients |
Q36926556 | Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings |
Q34416259 | Does the vagus nerve mediate the sixth sense? |
Q34959949 | Epidemiologic evidence on the comorbidity of depression and diabetes |
Q35189634 | Epidemiology of comorbid coronary artery disease and depression |
Q34696265 | Ethnic differences in the relationship between depressive symptoms and health-related quality of life in people with type 2 diabetes |
Q37111643 | Examining a bidirectional association between depressive symptoms and diabetes |
Q44946408 | Functional status before and after diagnosis of Type 2 diabetes |
Q91344997 | Gestational diabetes and postnatal depressive symptoms: A prospective cohort study in Western China |
Q36720395 | Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. |
Q38041962 | Health and psychosocial outcomes in U.S. adult patients with diabetes from diverse ethnicities |
Q36077076 | Health care expenditures associated with depression in adults with cancer |
Q44972543 | Health-related quality of life and quality of life in type 2 diabetes: relationships in a cross-sectional study |
Q50948142 | How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. |
Q82419223 | Impact of depression on diabetes mellitus |
Q38222121 | Incidence and risk of depression associated with diabetes in adults: evidence from longitudinal studies |
Q49885375 | Influence of Health Status on the Association Between Diabetes and Depression Among Adults in Europe: Findings From the SHARE International Survey |
Q33999111 | Interpersonal abuse and depression among mexican immigrant women with type 2 diabetes |
Q38117266 | Is depression a modifiable risk factor for diabetes burden? |
Q35692047 | Is the association between depressive symptoms and glucose metabolism bidirectional? Evidence from the English Longitudinal Study of Ageing |
Q45241023 | Longitudinal associations between depressive symptoms and type 2 diabetes and their impact on mortality in primary care patients |
Q41557280 | Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence. |
Q39521362 | Mental health and relational self-management experiences of patients with type 2 diabetes and stage 3 chronic kidney disease |
Q36760796 | Metabolic imbalance in affective disorders |
Q48933343 | More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic |
Q40785786 | Multimorbidity in adults from a southern Brazilian city: occurrence and patterns |
Q51244032 | Neural, Hormonal, and Cognitive Correlates of Metabolic Dysfunction and Emotional Reactivity. |
Q60643570 | No increased risk of developing depression in diabetes compared to other chronic illness |
Q39167835 | Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations |
Q48581368 | Patterns in the lives of African American women with diabetes |
Q90353008 | Positive Correlation of Serum N-Acetyl-β-hexosaminidase with Markers of Atherosclerosis in Diabetes Type 2 Patients with Mild Symptoms of Depression and Anxiety |
Q38583648 | Positive association between serious psychiatric outcomes and complications of diabetes mellitus in patients with depressive disorders |
Q59341220 | Pre-aging of the Olfactory Bulb in Major Depression With High Comorbidity of Mental Disorders |
Q45054837 | Predictors of incident major depression in diabetic outpatients with subthreshold depression |
Q36377600 | Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression |
Q42770313 | Prevalence and determinants of depression in type 2 diabetes patients: problem in generalization. |
Q37290202 | Prevalence of Depression in Patients with Type II Diabetes Mellitus and its Impact on Quality of Life |
Q90652567 | Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis |
Q34386921 | Prevalence of co-morbid depression in out-patients with type 2 diabetes mellitus in Bangladesh. |
Q35044632 | Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal |
Q34583452 | Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium |
Q35146838 | Prevalence of depressive symptoms and factors associated with it in type 2 diabetic patients: a cross-sectional study in China |
Q35533430 | Prevalence of major depressive episode in CKD. |
Q57384126 | Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes |
Q48697833 | Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project |
Q35905983 | Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study. |
Q34593857 | Psychological counselling in problematic diabetes: does it help? |
Q33813422 | Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? |
Q34986795 | Quality of care indicators, health behaviors, and physical functioning in adults with diabetes |
Q44923957 | Quality of life, health status and clinical outcomes in Type 2 diabetes patients |
Q47813282 | Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study |
Q34449542 | Relationship between glycemic control and depression among American Indians in the Strong Heart Study |
Q34277620 | Relationship between use of antidepressants and risk of fractures: a meta-analysis |
Q92435025 | Shared and unique risk factors for depression and diabetes mellitus in a longitudinal study, implications for prevention: an analysis of a longitudinal population sample aged ⩾45 years |
Q37626418 | Should we screen for emotional distress in type 2 diabetes mellitus? |
Q34098494 | State of the science: depression and type 2 diabetes |
Q37606303 | Stress as a risk factor for noncompliance with treatment regimens in patients with diabetes and hypertension |
Q36899384 | Study of fatigue, depression, and associated factors in type 2 diabetes mellitus in industrial workers |
Q47914277 | Suicidal ideation reported by adults with Type 1 or Type 2 diabetes: results from Diabetes MILES-Australia |
Q47207529 | Susto, coraje, and abuse: depression and beliefs about diabetes. |
Q89636593 | Synaptotagmin-7 is a key factor for bipolar-like behavioral abnormalities in mice |
Q57138675 | Systematic review of healthcare costs related to mental health conditions among cancer survivors |
Q38538401 | TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS. |
Q33693777 | The Interrelationship between Diabetes and Depression |
Q35884715 | The Metabolic Syndrome in Patients With Severe Mental Illnesses |
Q37438943 | The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus |
Q38220085 | The association between diabetes and depression: a very disabling condition. |
Q34866766 | The comorbidity of diabetes mellitus and depression |
Q34417848 | The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2. |
Q48576357 | The population perspective on quality of life among Americans with diabetes |
Q34959974 | Treatment of depression in diabetes: impact on mood and medical outcome |
Q46711196 | Treatment of depression in diagnosed diabetes: common cause or detection bias? |
Q93489594 | Treatment of patients with comorbid depression and diabetes with metformin and milnacipran |
Q62608522 | Using Passive Smartphone Sensing for Improved Risk Stratification of Patients With Depression and Diabetes: Cross-Sectional Observational Study |
Q35105836 | Vanadium-Enriched Cordyceps sinensis, a Contemporary Treatment Approach to Both Diabetes and Depression in Rats |
Q36593528 | Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men. |
Q52899061 | [Comorbidity of chronic somatic illness and psychological disorders. Problems in outpatient mental health care]. |
Q34580409 | triADD: the risk for alcohol abuse, depression, and diabetes multimorbidity in the American Indian and Alaska Native populations |
Search more.